Concourse Financial Group Securities, Inc. Fibrogen Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.3 - $0.58 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$0.33 - $1.26 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$0.89 - $2.36 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$0.73 - $2.73 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.38 - $0.91 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$0.79 - $2.83 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$0.79 - $2.83 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$13.27 - $17.73 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$11.4 - $14.6 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$7.94 - $12.96 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$12.02 - $16.79 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$9.93 - $15.39 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$10.18 - $26.64 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$31.0 - $55.72 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	SELL	$37.09 - $48.97 $2,225 - $2,938	-60 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $930 - $1,046	23 Added 62.16%	60 $2,000
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $1,279 - $1,778	37 New	37 $2,000
Q3 2019 Nov 13, 2019	SELL	$36.98 - $48.45 $1,368 - $1,792	-37 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $702 - $1,110	-20 Reduced 35.09%	37 $2,000
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $2,441 - $3,414	57 New	57 $3,000
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$56.3 - $67.25 $0 - $0	0 New	0 $0

Others Institutions Holding FGEN

# of Institutions

Shares Held

39.9M

Call Options Held

343K

Put Options Held

100K

Armistice Capital, LLC New York, NY

6.8M
Shares

$3.74 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$3.23 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

4.62M
Shares

$2.54 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$2.15 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$1.33 Million
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $51.6M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account